Browse 473 skin cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Filter
1
Filter results
Results: 473
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
for
Melanoma, Non-small Cell Lung Cancer,
Location: Fairfax VA, Pittsburgh PA, Grand Rapids MI, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07115043
Phase1, Phase2, Recruiting
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: New Haven CT, New York NY, Baltimore MD, Buffalo NY,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06172478
Phase2, Recruiting
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
for
Melanoma Stage III, Melanoma Stage IV
Location: La Jolla CA, San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT04598009
Phase2, Recruiting
Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH
for
Melanoma
Location: Houston TX
Sponsor: Genta Incorporated
Sex: All
Age: 18+
Code: NCT01092585
Phase2, Recruiting
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
for
Melanoma
Location: Pittsburgh PA
Sponsor: Yana Najjar
Sex: All
Age: 18+
Code: NCT04658303
Recruiting
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
for
Phase 1, Recurrent Melanoma, Refractory Melanoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06660420
Phase1, Recruiting
Adjuvant Quisinostat in High-Risk Uveal Melanoma
for
Uveal Melanoma
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 19+
Code: NCT06932757
Phase2, Recruiting
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
for
Locally Advanced or Metastatic Melanoma
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT05498792
Early_phase1, Recruiting
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
for
Pancreatic Cancer, Melanoma,
Location: Houston TX
Sponsor: Threshold Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03098160
Phase1, Recruiting
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
for
Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III,